Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 888.39 Million USD | 0.33% |
| 2023 | 900 Million USD | 50235.57% |
| 2022 | 1.78 Million USD | 48.14% |
| 2021 | 1.2 Million USD | 32.2% |
| 2020 | 913 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 9.95 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 3.9 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 28 Thousand USD | -63.64% |
| 2000 | 77 Thousand USD | -23.0% |
| 1999 | 100 Thousand USD | -50.0% |
| 1998 | 200 Thousand USD | 0.0% |
| 1997 | 200 Thousand USD | -33.33% |
| 1996 | 300 Thousand USD | -25.0% |
| 1995 | 400 Thousand USD | 0.0% |
| 1994 | - USD | -100.0% |
| 1993 | 100 Thousand USD | 0.0% |
| 1992 | 100 Thousand USD | -75.0% |
| 1991 | 400 Thousand USD | -33.33% |
| 1990 | 600 Thousand USD | -14.29% |
| 1989 | 700 Thousand USD | -36.36% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 886.91 Million USD | 0.08% |
| 2024 FY | 888.39 Million USD | -1.29% |
| 2024 Q4 | 888.39 Million USD | 0.08% |
| 2024 Q3 | 887.65 Million USD | 0.08% |
| 2024 Q1 | 886.17 Million USD | 0.08% |
| 2023 FY | 900 Million USD | 50235.57% |
| 2023 Q3 | 884.7 Million USD | -4.25% |
| 2023 Q2 | 923.96 Million USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | 885.43 Million USD | 0.08% |
| 2022 Q3 | 2.78 Million USD | 27.51% |
| 2022 FY | 1.78 Million USD | 48.14% |
| 2022 Q4 | 986.68 Million USD | 35379.61% |
| 2022 Q2 | 2.18 Million USD | -9.43% |
| 2022 Q1 | 2.4 Million USD | 99.5% |
| 2021 Q3 | 1.08 Million USD | 2.54% |
| 2021 Q2 | 1.06 Million USD | 9.94% |
| 2021 FY | 1.2 Million USD | 32.2% |
| 2021 Q1 | 966 Thousand USD | 5.81% |
| 2021 Q4 | 1.2 Million USD | 10.84% |
| 2020 FY | 913 Thousand USD | 0.0% |
| 2020 Q2 | 1.45 Million USD | 48.27% |
| 2020 Q3 | 1.46 Million USD | 0.76% |
| 2020 Q4 | 913 Thousand USD | -37.76% |
| 2020 Q1 | 982 Thousand USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2018 Q3 | 16.37 Million USD | -27.03% |
| 2018 Q4 | - USD | -100.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | 22.43 Million USD | 0.0% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | 18.66 Million USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q3 | 12.8 Million USD | 0.0% |
| 2006 FY | 9.95 Million USD | 0.0% |
| 2006 Q4 | 9.95 Million USD | -22.23% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q1 | 2.4 Million USD | -38.46% |
| 2005 Q2 | 2.45 Million USD | 2.38% |
| 2005 Q3 | 2.25 Million USD | -8.42% |
| 2005 Q4 | - USD | -100.0% |
| 2005 FY | - USD | -100.0% |
| 2004 Q4 | 3.9 Million USD | -15.22% |
| 2004 FY | 3.9 Million USD | 0.0% |
| 2004 Q3 | 4.6 Million USD | 48.39% |
| 2004 Q2 | 3.1 Million USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q1 | 16 Thousand USD | -42.86% |
| 2002 FY | - USD | -100.0% |
| 2002 Q2 | 4000.00 USD | -75.0% |
| 2002 Q3 | - USD | -100.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q1 | 65 Thousand USD | -15.58% |
| 2001 Q4 | 28 Thousand USD | -31.71% |
| 2001 Q3 | 41 Thousand USD | -22.64% |
| 2001 Q2 | 53 Thousand USD | -18.46% |
| 2001 FY | 28 Thousand USD | -63.64% |
| 2000 Q1 | 100 Thousand USD | 0.0% |
| 2000 Q4 | 77 Thousand USD | -13.48% |
| 2000 FY | 77 Thousand USD | -23.0% |
| 2000 Q3 | 89 Thousand USD | -11.0% |
| 2000 Q2 | 100 Thousand USD | 0.0% |
| 1999 FY | 100 Thousand USD | -50.0% |
| 1999 Q4 | 100 Thousand USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | -50.0% |
| 1999 Q2 | 200 Thousand USD | 0.0% |
| 1999 Q1 | 200 Thousand USD | 0.0% |
| 1998 Q1 | 200 Thousand USD | 0.0% |
| 1998 Q4 | 200 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | 0.0% |
| 1998 Q2 | 200 Thousand USD | 0.0% |
| 1998 FY | 200 Thousand USD | 0.0% |
| 1997 Q1 | 300 Thousand USD | 0.0% |
| 1997 Q4 | 200 Thousand USD | 0.0% |
| 1997 Q3 | 200 Thousand USD | 0.0% |
| 1997 Q2 | 200 Thousand USD | -33.33% |
| 1997 FY | 200 Thousand USD | -33.33% |
| 1996 Q3 | 300 Thousand USD | 0.0% |
| 1996 Q4 | 300 Thousand USD | 0.0% |
| 1996 Q2 | 300 Thousand USD | 0.0% |
| 1996 FY | 300 Thousand USD | -25.0% |
| 1996 Q1 | 300 Thousand USD | -25.0% |
| 1995 Q4 | 400 Thousand USD | 0.0% |
| 1995 FY | 400 Thousand USD | 0.0% |
| 1994 Q2 | - USD | -100.0% |
| 1994 FY | - USD | -100.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q1 | 100 Thousand USD | 0.0% |
| 1993 Q1 | 200 Thousand USD | 100.0% |
| 1993 FY | 100 Thousand USD | 0.0% |
| 1993 Q4 | 100 Thousand USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | 0.0% |
| 1992 FY | 100 Thousand USD | -75.0% |
| 1991 FY | 400 Thousand USD | -33.33% |
| 1991 Q4 | 400 Thousand USD | 0.0% |
| 1990 Q4 | 600 Thousand USD | 0.0% |
| 1990 FY | 600 Thousand USD | -14.29% |
| 1989 FY | 700 Thousand USD | -36.36% |
| 1989 Q4 | 700 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 7.17 Million USD | -12281.756% |
| Prenetics Global Limited | 867.21 Thousand USD | -102341.84% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -77488.734% |
| CareDx, Inc | 28.27 Million USD | -3041.633% |
| Exact Sciences Corporation | 2.47 Billion USD | 64.11% |
| Exagen Inc. | 19.23 Million USD | -4519.578% |
| Inotiv, Inc. | 399.4 Million USD | -122.426% |
| Guardant Health, Inc. | 1.13 Billion USD | 22.069% |
| Biodesix, Inc. | 35.22 Million USD | -2422.047% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -899418.038% |
| Precipio, Inc. | 106 Thousand USD | -838004.717% |
| iSpecimen Inc. | 29.13 Thousand USD | -3049645.966% |
| Natera, Inc. | 282.94 Million USD | -213.98% |
| Aspira Women's Health Inc. | 1.43 Million USD | -62025.245% |
| Standard BioTools Inc. | 3.98 Million USD | -22204.569% |
| 23andMe Holding Co. | 67.84 Million USD | -1209.442% |
| Castle Biosciences, Inc. | 14.19 Million USD | -6157.156% |
| Personalis, Inc. | 1.23 Million USD | -71892.788% |
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -28800.163% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -120088.944% |
| OpGen, Inc. | 2.02 Million USD | -43844.597% |
| T2 Biosystems, Inc. | 6.59 Million USD | -13364.55% |
| Myriad Genetics, Inc. | 130.9 Million USD | -578.679% |
| ICON Public Limited Company | 3.66 Billion USD | 75.763% |
| NeoGenomics, Inc. | 606.06 Million USD | -46.582% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -77488.734% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -42.626% |
| RadNet, Inc. | 812.06 Million USD | -9.399% |
| MDxHealth SA | 35.56 Million USD | -2398.006% |
| Psychemedics Corporation | 945 Thousand USD | -93909.63% |
| Illumina, Inc. | 1.48 Billion USD | 40.336% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 79.17 Million USD | -1022.088% |
| DarioHealth Corp. | 24.59 Million USD | -3512.667% |
| Fulgent Genetics, Inc. | 10.11 Million USD | -8686.381% |
| Sera Prognostics, Inc. | 840 Thousand USD | -105660.833% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -462454.279% |
| OPKO Health, Inc. | 222.03 Million USD | -300.115% |
| Medpace Holdings, Inc. | 142.12 Million USD | -525.09% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -1092309.375% |
| Prenetics Global Limited | 867.21 Thousand USD | -102341.84% |
| Mainz Biomed B.V. | 2.19 Million USD | -40357.009% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -79329.273% |
| Trinity Biotech plc | 54.65 Million USD | -1525.571% |
| Neuronetics, Inc. | 59.28 Million USD | -1398.559% |
| Sotera Health Company | 2.22 Billion USD | 60.049% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -79329.273% |